Target intelligence / Profile preview

Bacterial 30S ribosomal subunit A-site decoding center (30S A-site)

Target
30S A-site
Molecular classification
Ribonucleoprotein complex, Ribosomal subunit, RNA-protein complex
01

Overview

The bacterial 30S ribosomal subunit A-site decoding center is a fundamental functional region within the small ribosomal subunit responsible for ensuring the accuracy of protein synthesis. It is primarily composed of the 16S ribosomal RNA (rRNA), where highly conserved nucleotides, specifically A1492 and A1493, monitor the fidelity of the codon-anticodon interaction between mRNA and aminoacyl-tRNA (Vicens & Westhof, 2001, PMID: 11130709). This site serves as a major therapeutic target for several classes of antibiotics, including aminoglycosides and tetracyclines. Aminoglycosides bind to the decoding center and stabilize an 'active' conformation of the rRNA, which forces the ribosome to accept near-cognate tRNAs, leading to the production of mistranslated, toxic proteins and subsequent bacterial cell death (Carter et al., 2000, PMID: 10591205). In contrast, tetracyclines bind to the A-site to physically block the entry of aminoacyl-tRNA, thereby halting the elongation phase of translation (Brodersen et al., 2000, PMID: 11130710). Because the structural features of the bacterial A-site differ significantly from the eukaryotic 40S subunit, these drugs exhibit selective toxicity against pathogens. Understanding the molecular architecture of this decoding center is critical for overcoming antibiotic resistance mechanisms, such as rRNA methylation or target site mutations.

Other names
30S decoding site16S rRNA A-siteAminoacyl-tRNA binding siteRibosomal decoding centerSmall ribosomal subunit A-site
02

Mechanism of action

Inhibition of protein synthesis via induction of mRNA misreading (mistranslation) or steric blockade of aminoacyl-tRNA binding to the A-site.

03

Biological functions

Protein synthesisTranslationmRNA decodingtRNA selectionGenetic code translation fidelity
04

Disease associations

Bacterial infection
05

Safety considerations

Ototoxicity (vestibular and auditory)NephrotoxicityNeuromuscular blockadeDevelopment of multidrug-resistant (MDR) bacterial strains
06

Interacting drugs

Gentamicin

12 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)16S rRNA gene mutations (e.g., A1408G)Aminoglycoside-modifying enzymes (AMEs)

Beyond the preview

Go deeper on Bacterial 30S ribosomal subunit A-site decoding center (30S A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 30S ribosomal subunit A-site decoding center (30S A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call